UPDATE: SunTrust Starts Alexion Pharmaceuticals (ALXN) at Buy; Stock Discounting Risks While Pipeline Underappreciated
(updated to add analyst comments)SunTrust analyst Robyn Karnauskas initiates coverage on ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)